WEDNESDAY, Jan. 27, 2021 — People who’ve recovered from severe COVID-19 may have stronger long-term immune protection from reinfection than those with milder illness, researchers report.
They examined blood samples from 39 COVID-19 patients and 10 people who hadn’t been exposed to the virus (their blood samples were given pre-pandemic). In all, they analyzed the expression of individual genes of more than 80,000 CD8+ T-cells.
CD8+ T-cells are immune cells that destroy virus-infected host cells, and “memory” CD8+ T-cells protect the body from reinfection by many types of viruses.
Of the COVID-19 patients, 17 had milder illness and weren’t hospitalized, 13 had been hospitalized, and nine ended up in intensive care. The researchers were surprised to find that patients with milder COVID-19 had weaker CD8+ T-cell responses.
The strongest CD8+ T-cell responses were in severely ill patients who required hospitalization or intensive care.
“There is an inverse link between how poorly T-cells work and how bad the infection is,” study co-author Dr. Christian Ottensmeier said in a news release from the La Jolla Institute for Immunology in California. He’s a professor at the University of Liverpool in the U.K. and an adjunct professor at the La Jolla institute.
The researchers found that CD8+ T-cells in people with mild COVID-19 had signs of T-cell “exhaustion,” in which cells receive so much immune system stimulation to combat viruses that they become less effective.
T-cell exhaustion in people with mild COVID-19 may reduce their chances of long-term immunity, according to the authors.
“People who have severe disease are likely to end up with a good number of memory cells,” explained study co-author Pandurangan Vijayanand, a professor at La Jolla Institute. “People with milder disease have memory cells, but they seem exhausted and dysfunctional — so they might not be effective for long enough.”
The findings “suggest that suggest people with severe COVID-19 cases may have stronger long-term immunity,” Vijayanand said.
This study highlights the enormous variability in how human beings react to a viral challenge, Ottensmeier said.
While the study offers important new insight into COVID-19 patients’ immune response, it’s limited due to its reliance on CD8+ T-cells found in blood samples, the researchers explained.
To learn more, they plan to assess T-cells in tissues hit hardest by the new coronavirus, such as the lungs, to see how they react to the virus. That’s crucial because the memory T-cells that provide long-term immunity need to live in the tissues.
The study was published Jan. 21 in the journal Science Immunology.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022